Table 1.
Subject Characteristics.
| Parameter | Median | Q1 – Q3 |
|---|---|---|
| Age (years) | 36 | 28 – 45 |
| HIV-1 RNA (log10 copies/mL) | 4.5 | 4.0 – 5.1 |
| CD4 cell count (/mm3) | 349 | 207 – 455 |
| Time since HIV diagnosis (months) | 5.7 | 2.4 – 31.5 |
| Framingham risk score (% 10-year risk) | 1 | 1 – 3 |
| Systolic blood pressure (mmHg) | 117 | 108 –125 |
| Diastolic blood pressure (mmHg) | 75 | 68 – 80 |
| Creatinine (mg/dL) | 0.9 | 0.8 – 1.0 |
| Fasting glucose (mg/dL) | 84 | 77 – 91 |
| Body Size and Composition | ||
| Height (cm) | 175 | 169 – 180 |
| Weight (kg) | 77 | 67 – 87 |
| Body-mass index (kg/m2) | 25 | 22 – 28 |
| Waist circumference (cm) | 88 | 81 – 98 |
| Total body fat mass (kg) | 17 | 11 – 24 |
| Total body lean mass (kg) | 56 | 50 – 63 |
| Lipids and Lipoproteins | ||
| Total cholesterol (mg/dL) | 155 | 134 – 180 |
| Triglycerides (mg/dL) | 102 | 70 – 148 |
| HDL cholesterol (mg/dL) | 38 | 31 – 45 |
| Calculated low-density lipoprotein cholesterol (mg/dL) | 93 | 74 –115 |
| Total LDL particles (nmol/L) | 1076 | 884 –1286 |
| Small LDL particles (nmol/L) | 669 | 449 – 862 |
| Mean LDL particle size (nm) | 20.5 | 20.1 – 20.9 |
| Total HDL particles (umol/L) | 29.3 | 25.7 – 32.9 |
| Small HDL particles (umol/L) | 16.6 | 13.1 – 19.6 |
| Inflammatory Markers and Adipocytokines | ||
| Pro-inflammatory HDL (log10 FU/min) | 4.3 | 4.3 – 4.3 |
| C-reactive protein(mg/L) | 1.4 | 0.7 – 3.0 |
| Interleukin-6 (pg/mL) | 1.8 | 1.2 – 3.0 |
| Adiponectin (ng/mL) | 7780 | 5355 – 11540 |
| Leptin (pg/mL) | 5288 | 3017 – 9558 |
| Ultrasonographic Markers | ||
| Common CIMT (mm) | 0.64 | 0.59 – 0.70 |
| Bifurcation CIMT (mm) | 0.74 | 0.65 – 0.82 |
| Brachial artery FMD (%) | 4.5 | 3.0 – 6.3 |
| Brachial artery diameter (mm) | 4.25 | 3.84 – 4.55 |